Contemporary use of antiplatelet therapies in percutaneous coronary interventions

被引：2
作者：
Saw, J [1 ]
Moliterno, DJ [1 ]
机构：
[1] Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH 44195 USA
来源：
CORONARY ARTERY DISEASE | 2003年 / 14卷 / 05期
关键词：
antiplatelet agents; stents; angioplasty; aspirin; thienopyridine; glycoprotein IIb/IIIa inhibitors; clopidogrel;
D O I：
10.1097/00019501-200308000-00004
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：373 / 380
页数：8
相关论文
共 50 条
[31]   Antiplatelet therapies in combination for the treatment of patients with stable and unstable coronary artery disease [J].
Aviles, RJ ;
Bhatt, DL .
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2002, 13 (03) :177-182
[32]   Antiplatelet Therapies in Combination for the Treatment of Patients with Stable and Unstable Coronary Artery Disease [J].
Ronnier J. Aviles ;
Deepak L. Bhatt .
Journal of Thrombosis and Thrombolysis, 2002, 13 :177-182
[33]   Antiplatelet effect of clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions - Limited inhibition of the P2Y12 receptor [J].
Lepantalo, Aino ;
Virtanen, Kari S. ;
Resendiz, Julio C. ;
Mikkelsson, Jussi ;
Viiri, Leena E. ;
Karhunen, Pekka J. ;
Lassila, Riita .
THROMBOSIS RESEARCH, 2009, 124 (02) :193-198
[34]   Platelet inhibition in percutaneous coronary interventions [J].
Wyss, CA ;
Roffi, M .
HERZ, 2005, 30 (03) :189-196
[35]   Antiplatelet therapies and the role of antiplatelet resistance in acute coronary syndrome [J].
Dupont, Allison G. ;
Gabriel, Don A. ;
Cohen, Mauricio G. .
THROMBOSIS RESEARCH, 2009, 124 (01) :6-13
[36]   Considerations in patients receiving oral antiplatelet therapy after acute coronary syndrome and percutaneous coronary intervention [J].
Roffman, David S. .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (15) :S18-S24
[37]   Clinical dilemmas on managing antiplatelet therapies after percutaneous coronary intervention: benefits versus risks [J].
Valgimigli, Marco .
CURRENT OPINION IN CARDIOLOGY, 2011, 26 :S1-S3
[38]   Contemporary Antiplatelet Treatment in Acute Coronary Syndrome Patients with Impaired Renal Function Undergoing Percutaneous Coronary Intervention [J].
Davlouros, Periklis ;
Xanthopoulou, Ioanna ;
Goudevenos, John ;
Hamilos, Michalis ;
Vavuranakis, Emmanouil ;
Sitafidis, George ;
Kanakakis, Ioannis ;
Deftereos, Spyridon ;
Alexopoulos, Dimitrios .
CARDIOLOGY, 2017, 138 (03) :186-194
[39]   Optimizing antiplatelet therapy in coronary interventions [J].
King, SB .
CLINICAL CARDIOLOGY, 2000, 23 (11) :8-13
[40]   Optimal Antiplatelet Therapy During Percutaneous Coronary Interventions Includes Glycoprotein IIb/IIIa Inhibitors Just Eliminate the Infusion [J].
Mahmud, Ehtisham ;
Prasad, Anand .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) :846-848
12345